VT

Venkat R. Thalladi

TI Theravance Biopharma R&D Ip: 4 patents #5 of 40Top 15%
📍 Foster City, CA: #31 of 463 inventorsTop 7%
🗺 California: #4,911 of 60,411 inventorsTop 9%
Overall (2018): #33,844 of 503,207Top 7%
4
Patents 2018

Issued Patents 2018

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
10100021 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Adam D. Hughes, Melissa Fleury, Miroslav Rapta, Gene Timothy Fass, Michael Simeone 2018-10-16
10072026 Crystalline form of 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile Xiaojun Huang 2018-09-11
9872855 (2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Miroslav Rapta 2018-01-23
9868698 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid Adam D. Hughes, Erik Fenster, Melissa Fleury, Anne-Marie Beausoleil, Jerry Nzerem +1 more 2018-01-16